Key result
In healthy, physically active females, early and late postmenopausal status was not associated with reduced peripheral or cerebrovascular function compared to premenopausal status.
Why the study?
Cardiovascular and cerebrovascular disease risk increases in ageing females coinciding with menopause, but differences in peripheral and cerebrovascular function across menopausal stages are poorly characterized.
Does postmenopausal status decrease peripheral and cerebrovascular function in healthy, physically active females?
Cross-Sectional (n=39)
No
Does postmenopausal status decrease peripheral and cerebrovascular function in healthy, physically active females?
In healthy, physically active females, peripheral and cerebrovascular function appears well preserved across the menopausal transition, contrary to assumptions that estrogen loss inevitably causes rapid vascular decline.
Answers are grounded in this paper and cite their sources.
Preserved vascular function across menopause in active females should not yet change practice; leaves open whether activity mitigates estrogen effects in other groups.
The risk of cardiovascular and cerebrovascular disease increases in ageing females, coinciding with the onset of menopause. Differences in peripheral and cerebrovascular function across menopausal stages, however, are poorly characterized. The aim of this study was to compare peripheral and cerebrovascular function between healthy premenopausal (PRE), early (1–6 years after final menstrual period; E‐POST) and late (>6 years after final menstrual period; L‐POST) postmenopausal females. We also explored the association between reproductive hormones, NO bioavailability and cerebrovascular function. In 39 females (40–65 years of age), we measured arterial stiffness, brachial artery flow‐mediated dilatation, and cerebrovascular reactivity (CVR) to hypercapnia in the middle (MCAv) and internal (ICA) carotid arteries. Follicle‐stimulating hormone, estradiol, progesterone and plasma nitrate and nitrite concentrations were also measured. Years since final menstrual period (PRE, 0 ± 0 years; E‐POST, 3 ± 1 years; L‐POST, 11 ± 4 years; P < 0.001) and estradiol levels (PRE, 145.5 ± 65.6 pg ml −1 ; E‐POSTm 30.2 ± 81.2 pg ml −1 ; L‐POST, 7.7 ± 11.3 pg ml −1 ; P < 0.001) were different between groups. All groups exceeded the guidelines for recommended physical activity. There were no group differences in blood pressure ( P = 0.382), arterial stiffness ( P = 0.129), flow‐mediated dilatation ( P = 0.696) or MCAv CVR ( P = 0.442). The ICA CVR blood flow response was lower in PRE compared with L‐POST (26.5 ± 19.2 vs. 47.8 ± 12.6%; P = 0.010), but after adjusting for age these differences were no longer present. Flow‐mediated dilatation ( r = 0.313, P = 0.105) and ICA CVR ( r = −0.154, P = 0.495) were not associated with the estradiol concentration. There were no associations between the estradiol concentration and NO bioavailability. These results suggest that in healthy, physically active early and late postmenopausal females, vascular and cerebrovascular function is generally well preserved.
No takes yet. Share an insight, caveat, or question.
Ruediger et al. (2023) conducted a cross-sectional in Healthy females assessing vascular function across menopause stages (n=39). Postmenopausal status (early and late) vs. Premenopausal status was evaluated on Peripheral vascular function (brachial artery flow-mediated dilatation) (p=0.696). In healthy, physically active females, early and late postmenopausal status was not associated with reduced peripheral or cerebrovascular function compared to premenopausal status.
Synapse has enriched 10 related papers. Consider them for comparative context: